Hutch News

Pricey whole-body MRIs don’t add up

Pricey whole-body MRIs don’t add up

For cancer screening, proven methods tailored to an individual’s risk level make more sense
Hutch NewsAugust 28, 2025
International symposium focuses on lobular breast cancer

International symposium focuses on lobular breast cancer

Clinicians, researchers and patients from around the world gather in Pittsburgh to honor Seattle advocate, discuss understudied disease
Hutch NewsOctober 06, 2023
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch NewsDecember 18, 2020
Trio of studies to evaluate metastatic breast cancer care

Trio of studies to evaluate metastatic breast cancer care

Hutch researcher awarded grants to study the use of biopsy to drive therapy choices and test new type of PET scan to stage lobular
Hutch NewsJuly 20, 2020
What’s new in prostate cancer? 5 things to watch

What’s new in prostate cancer? 5 things to watch

Highlights from the Institute for Prostate Cancer Research 2017 community symposium
Hutch NewsMarch 22, 2017
‘True risk’ of breast cancer: MRI could more precisely pinpoint chances of developing disease

‘True risk’ of breast cancer: MRI could more precisely pinpoint chances of developing disease

Study finds a screening byproduct, once thought to be clinically insignificant, is useful in predicting the likelihood of breast cancer in high-risk women
Hutch NewsDecember 04, 2014